dc.contributor.author | Aubdool, AA | en_US |
dc.contributor.author | Argunhan, F | en_US |
dc.contributor.author | Thakore, P | en_US |
dc.contributor.author | Brain, SD | en_US |
dc.date.accessioned | 2018-08-21T08:21:28Z | |
dc.date.issued | 2018-03-13 | en_US |
dc.date.submitted | 2018-07-19T10:08:37.993Z | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/43644 | |
dc.description.sponsorship | . | en_US |
dc.format.extent | 1201 - 1202 | en_US |
dc.language | eng | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Circulation | en_US |
dc.subject | Calcitonin Gene-Related Peptide | en_US |
dc.subject | Cardiomegaly | en_US |
dc.subject | Heart Failure | en_US |
dc.subject | Humans | en_US |
dc.subject | Hypertension | en_US |
dc.title | Response by Aubdool et al to Letters Regarding Article, "A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure". | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1161/CIRCULATIONAHA.117.031848 | en_US |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/29530898 | en_US |
pubs.issue | 11 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 137 | en_US |